Flex24 Pain
NDC Package 54641-005-01
Package Information
Flex24 Pain is adults and children over the age of 12:Remove plastic backing from patch and discardApply one patch to affected areaRepeat if necessary, but no more than 3 per dayPatch shold be comfortable but not tightChildren under 12: consult a doctor before use. Marketed by Larasan Pharmaceutical Corporation, this product is identified by NDC 54641-005 and is authorized under FDA application part348.
Identification & Billing
- RxCUI: 1364993 - camphor 3 % / menthol 2.52 % Medicated Patch
- RxCUI: 1364993 - camphor 0.03 MG/MG / menthol 0.0252 MG/MG Medicated Patch
- RxCUI: 1494222 - FLEX24 PERFORMANCE 3 % / 2.52 % Medicated Patch
- RxCUI: 1494222 - camphor 0.03 MG/MG / menthol 0.0252 MG/MG Medicated Patch [Flex24 Performance]
- RxCUI: 1494222 - Flex24 Performance (camphor 3 % / menthol 2.52 % ) Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54641 - Larasan Pharmaceutical Corporation
- 54641-005 - Flex24 Pain
- 54641-005-01 - 7 PATCH in 1 PACKAGE / 1.56 g in 1 PATCH
- 54641-005 - Flex24 Pain
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54641-005-01 identifies a specific commercial package of 7 patch in 1 package / 1.56 g in 1 patch of Flex24 Pain, labeled by Larasan Pharmaceutical Corporation. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Larasan Pharmaceutical Corporation on September 12, 2014. The current certification is valid through December 31, 2020.
How is this Larasan Pharmaceutical Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54641000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.